Approval · Notice of Compliance 27704 · 2022
COVIFENZ: Notice of Compliance 27704
Issued February 24, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27704
- Date
- February 24, 2022
- Company
- Medicago IncQuebec, Quebec, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| COVIFENZ | 02521326 | Cancelled Pre Market |
Medicinal ingredients
- VIRUS-LIKE PARTICLES (VLP) OF SARS-COV-2 SPIKE PROTEIN 3.75 MCG per 0.5ML